Life Science News

RSS

Cancers caused by bacterial toxin might be preventable

Studying DNA mutations in cancers can help clarify how cancers develop and what makes cancer cells different from normal, healthy cells.

27 Jul 2020

Study provides new insights into the host cellular response to SARS-CoV-2 infection

The COVID-19 pandemic caused by the new coronavirus has created an unprecedented public health challenge globally. Little was known about how the infecting cells respond to the virus and how the virus hijacks the host cellular machinery.

27 Jul 2020

Curi Bio Acquires Dana Solutions

Curi Bio has acquired Dana Solutions, a pioneer in the application of artificial intelligence and machine learning to in vitro cell-based assays.

From Curi Bio 27 Jul 2020

Continuous survival of neurons is intrinsically programmed during development

When our neurons -- the principle cells of the brain -- die, so do we.Most neurons are created during embryonic development and have no "backup" after birth. Researchers have generally believed that their survival is determined nearly extrinsically, or by outside forces, such as the tissues and cells that neurons supply with nerve cells.

25 Jul 2020

Researchers use new approach to unravel the mechanisms that lie behind tetraploidy

Cell division is a fundamental process that organisms need to reproduce, grow, and make repairs. But when an error disrupts this complex biological process, cellular abnormalities can lead to diseases, such as cancer, where cells are enabled to grow and divide out of control.

25 Jul 2020

Study identifies mechanisms that underlie olfactory symptoms of COVID-19

A new study of human olfactory cells has revealed that viral invasion of supportive cells in the nasal cavity might be driving the loss of smell seen in some patients with COVID-19.

25 Jul 2020

Animal Free Research UK condemns the wasted opportunity to make real progress in reducing animal experiments

Animal Free Research UK has today condemned yet another wasted opportunity to make real progress with a decrease of just 3.4% in experiments on animals in GB laboratories in 2019, announced by the Home Office this morning.

25 Jul 2020

Experimental mRNA-based COVID-19 vaccine elicits protective immune responses in animals

An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice and non-human primates, researchers report on July 23rd in the journal Cell.

24 Jul 2020

UCC Innovation launches new spinout company SeqBiome

UCC Innovation today announced the launch of SeqBiome a spinout from APC Microbiome Ireland, SFI Research Centre, University College Cork and Teagasc (the Irish Agriculture and Food Development Authority).

24 Jul 2020

Scientists discover how coronavirus enters cells without encountering immune system resistance

With an alarm code, we can enter a building without bells going off. It turns out that the SARS coronavirus 2 (SARS-CoV-2) has the same advantage entering cells. It possesses the code to waltz right in.

24 Jul 2020

Arctoris supports global research efforts to combat COVID-19

Arctoris Ltd. supports global research efforts to find new therapeutics against COVID-19.

24 Jul 2020

SphingoTec launches point-of-care test for bio-ADM, a biomarker for life threatening endothelial dysfunction

Diagnostics company SphingoTec GmbH today announced the launch of its IB10 sphingotest® bio-ADM®, a CE-IVD-marked point-of-care test to quantitatively determine blood levels of Bioactive Adrenomedullin. Blood levels of bio-ADM® reflect in real-time the functional status of the endothelium, the inner cell sheet of blood vessels.

24 Jul 2020

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

Olympus, a leading manufacturer of high-end research microscopes, and Cytosurge, a precision manufacturer of cell manipulation technologies, have entered a co-marketing agreement to become a complete system provider to the scientific community’s growing need for next-generation single-cell and CRISPR genetic manipulation solutions.

From Evident Corporation - Life Sciences 24 Jul 2020

Boehringer Ingelheim and Biognosys join forces on applying quantitative proteomics tools in drug discovery

Biognosys announced today that it started working together with Boehringer Ingelheim.

From Biognosys 24 Jul 2020

Researchers to create expert recommendations for vulture poisoning control efforts in Southern Africa

University of Maryland (UMD) researchers across multiple colleges collaborated with other international leaders in wildlife conservation to produce an expert assessment and recommendations for vulture poisoning control efforts in Southern Africa.

24 Jul 2020

Life science diagnostic start up is seeing growing interest and support for disease detection tests

A Purdue University-affiliated life science diagnostic startup is seeing growing interest and support for its innovations focused on detecting and pre-empting the risks of debilitating diseases such as certain cancers.

24 Jul 2020

Researchers use optogenetics to activate and inactivate signaling pathways

Proper embryonic development of the fruit fly Drosophila melanogaster is governed by patterns of protein activity bequeathed to the fertilized egg by its mother.

24 Jul 2020

New genome-editing technologies can help understand disease-associated genetic mutations

New genome-editing technologies developed by researchers in J. Keith Joung's laboratory at the Massachusetts General Hospital (MGH) have the potential to help understand disease-associated genetic mutations that are based on C-to-G (cytosine to guanine) single base changes.

24 Jul 2020

Century-old mercury pollution is persistent in Connecticut's Still River

Western Connecticut is known for rolling hills, rich history, and industry, such as hat making. Once called the "Hat City of the World," Danbury thrived.

23 Jul 2020

Epigenomic modifications play key role in the development of lung tumors

As cancer cells evolve, many of their genes become overactive while others are turned down. These genetic changes can help tumors grow out of control and become more aggressive, adapt to changing conditions, and eventually lead the tumor to metastasize and spread elsewhere in the body.

23 Jul 2020

Life Science News

Cancers caused by bacterial toxin might be preventable

Study provides new insights into the host cellular response to SARS-CoV-2 infection

Curi Bio Acquires Dana Solutions

Continuous survival of neurons is intrinsically programmed during development

Researchers use new approach to unravel the mechanisms that lie behind tetraploidy

Study identifies mechanisms that underlie olfactory symptoms of COVID-19

Animal Free Research UK condemns the wasted opportunity to make real progress in reducing animal experiments

Experimental mRNA-based COVID-19 vaccine elicits protective immune responses in animals

UCC Innovation launches new spinout company SeqBiome

Scientists discover how coronavirus enters cells without encountering immune system resistance

Arctoris supports global research efforts to combat COVID-19

SphingoTec launches point-of-care test for bio-ADM, a biomarker for life threatening endothelial dysfunction

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

Boehringer Ingelheim and Biognosys join forces on applying quantitative proteomics tools in drug discovery

Researchers to create expert recommendations for vulture poisoning control efforts in Southern Africa

Life science diagnostic start up is seeing growing interest and support for disease detection tests

Researchers use optogenetics to activate and inactivate signaling pathways

New genome-editing technologies can help understand disease-associated genetic mutations

Century-old mercury pollution is persistent in Connecticut's Still River

Epigenomic modifications play key role in the development of lung tumors

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News